← FDA Drug Approvals (Drugs@FDA)

GRISACTIN

NDA · New Drug Application · Sponsor: WYETH AYERST · Approved 1962-08-22

Drug application

FDA Application #

NDA050051

Application type

New Drug Application

Brand name

GRISACTIN

Generic name

Griseofulvin, Microcrystalline

Active ingredients

GRISEOFULVIN, MICROCRYSTALLINE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

WYETH AYERST

First approval

1962-08-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown